ME Therapeutics Holdings, Inc. (TSE:METX) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
ME Therapeutics Holdings Inc. is making significant strides in its drug development pipeline, with plans to advance its lead anti-G-CSF antibody candidate towards clinical trials. The company is also expanding its research capabilities by moving into new lab facilities and exploring partnership opportunities to enhance its drug pipeline.
For further insights into TSE:METX stock, check out TipRanks’ Stock Analysis page.